baber/WOPTO huggingface dataset:
Patent NZ-224410-A (NZ)
Title: Polyunsaturated polysiloxanes; polymers and copolymers and contact lenses made therefrom
Inventor: MUELLER K F
IPC: C08G77/388
Filed: 1988-04-28
Abstract: Disclosed is a poly-unsaturated polysiloxane of the formula I, <CHEM> wherein at least three of A are a reactive vinyl containing group as defined in the specification and the further variables are as defined in the specification. The invention concerns even polymers of those compounds and copolymers thereof with up to 95 % of one or more hydrophilic or hydrophobic reactive vinyl monomers, or mixture thereof. The respective (co)polymers are suitable for the manufacture of contact lenses.
Patent NZ-225306-A (NZ)
Title: Alpha-c-alkylation of the 8-acyl group on mevinolin and its analogues
Inventor: ASKIN DAVID
IPC: C07D309/30
Filed: 1988-07-06
Abstract: A process for alkylating the alpha position of the 8-acyl side chain in mevinolin and analogs thereof is disclosed. The process proceeds with a single charge of base and alkyl halide to give products with a pharmaceutically acceptable purity.
Patent NZ-237404-A (NZ)
Title: Bacillus thuringiensis cry iii(c) gene, bacterium, and plants transformed therewith and insecticidal compositions containing coleopteran-toxin protein
Inventor: DONOVAN WILLIAM P
IPC: A01N63/50
Filed: 1991-03-12
Abstract: The present invention relates to a method of enhancing the insecticidal activity of an insecticidal composition containing a coleopteran-toxic protein comprising incorporating into an insecticidal composition containing CryIII protein an amount of CryI protein effective to enhance the insecticidal activity of the composition against coleopteran insects.
Patent NZ-250878-A (NZ)
Title: Substituted sulphamoyl derivatives and medicaments
Inventor: CHRISTOPHE BERNARD
IPC: C07C311/18
Filed: 1994-02-15
Abstract: The subject of the invention is compounds of formula I <IMAGE>  in which   Ar1 represents optionally substituted naphthyl, phenyl, quinolyl or isoquinolyl;   Ar2 represents optionally substituted phenyl or thienyl; R1, R2 and R'2 represent, independently of each other, H, (C1-C4)alkyl or R1 represents nothing and N is linked to Ar2 and, optionally, R2 and R'2 form a double bond,   or R1 or R2 is linked to Ar2 and represents (C1-C3)alkylene; R3 and R4, which are identical or different, represent H, (C1-C4)alkyl or form with the nitrogen atom to which they are attached a saturated (C5-C7)heterocycle;   Z1 represents (C1-C12)alkylene; Q1 represents methyl, amino, (C1-C4)alkoxycarbonylamino, (C1-C4)alkylamino, di(C1-C4)alkylamino, pyrrolidinyl, piperidino, morpholino, piperazinyl, 4-(C1-C4)alkyl piperazinyl, amidino, (C1-C4)alkylamidino, guanidino, (C1-C4)alkylguanidino, pyridyl, imidazolyl, pyrimidinyl, indolyl, hydroxyl, (C1-C4)alkoxy, (C2-C8)alkoxycarbonyl, amino(C1-C4)alkyl-N-(C1-C4)alkylamino, carbamoyl or phenyl which is optionally substituted;   Q2 represents H or (C1-C4)alkyl; Q3 represents H or (C1-C4)alkyl or Q1 and Q3 are linked to form a heterocycle and represent together (C2-C3)alkylene whereas Z1 represents nothing, in the form of pure enantiomers or of mixtures thereof in any proportions,  as well as their salts with acids. These compounds have an affinity for the biological receptors of neuropeptide Y (NPY) which are present in the central and peripheral nervous systems.
Patent NZ-270430-A (NZ)
Title: Composition comprising refractory material, phenolic novolac resin and a triazine resin in sufficient amount to cure the novolac
Inventor: GERBER ARTHUR HARRY
IPC: C04B35/66
Filed: 1995-02-01
Abstract: A binder composition of a phenolic novolac resin and a (lower) alkoxylated triazine-formaldehyde resin curing agent is disclosed. The triazine resins have sufficient carbon atoms in the alkoxy groups so as to provide a curing agent having a water solubility of less than 15%. The binder cures at high temperatures so as to provide improved flow and prolonged workability to the composition. The compositions are useful in refractory applications having a need for high temperature curing agents such as for maintenance and repair within refractory vessels by gunning/spraying, manufacture of electrodes by the Soderberg method, and for use in blast furnace tap holes.
Patent NZ-284910-A (NZ)
Title: Electronic digital image control: closed loop analysis with statistical image quality metrics
Inventor: REITAN RONALD C
IPC: G06F3/048
Filed: 1995-04-21
Abstract: A system, apparatus and method for testing the functional components of an electronic digital imaging system is described. The system includes apparatus for image acquisition, storage, display, communication and printing. The system relies on a closed loop analysis to test system components by measuring a set of statistical image quality metrics. The expected set of statistics are in the form of special purpose features stored as a data set representative of an expected reference object. The closed loop analysis measures, for example, the quality of the printing component of the system by outputting a copy of the expected reference image, using the acquisition component to input the copy of the expected reference image, and then comparing the statistics against threshold values representative of an ideally operating component. The comparison of statistics against the threshold values provides a go/no-go measure of component performance and can indicate sources of system degradation.
Patent NZ-305796-A (NZ)
Title: A nucleic acid probe for detecting e. coli o157:h7, isolated nucleic acid molecule consisting of at least 15 contiguous nucleotides
Inventor: TARR PHILLIP I
IPC: C12Q1/68
Filed: 1996-04-12
Abstract: An isolated nucleic acid molecule that hybridizes under stringent conditions to SEQ ID NO:1 or its complement and to the DNA of enterohemorrhagic E. coli O157:H7 but not to the DNA of enteropathogenic E. coli O55:H7.
Patent NZ-312299-A (NZ)
Title: Substituted liposaccharides useful in the treatment and prevention of endotoxemia
Inventor: CHRIST WILLIAM J
IPC: A61P31/04
Filed: 1996-06-05
Abstract: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
Patent NZ-312720-A (NZ)
Title: Metal complexes of polyaminoacids, and their utilization in diagnostic imaging
Inventor: MEYER DOMINIQUE
IPC: C07D257/02
Filed: 1996-06-25
Abstract: PCT No. PCT/FR96/00992 Sec. 371 Date Dec. 29, 1997 Sec. 102(e) Date Dec. 29, 1997 PCT Filed Jun. 25, 1996 PCT Pub. No. WO97/01359 PCT Pub. Date Jan. 16, 1997The invention concerns gadolinium complexes of formula:    <IMAGE>  I  in which R represents a group of formula:   <IMAGE>    in which X is Br or I; R1 is H or optionally hydroxylated alkyl; R2 is hydroxylated alkyl; or alternatively R1 is H and R2 is a group of formula:    <IMAGE>  A  X being as defined above, and R'1 and R'2 being as defined for R1 and R2 excepted that they do not represent A, provided that -CO-NR1R2 or -CO-NR'1R'2 comprises at least 2 hydroxyl groups, and M represents H or the cation of an inorganic or organic base.
Patent NZ-323928-A (NZ)
Title: Optical recording medium, recording layer inlcudes partial mirror and thick reflective layer forming fabry-perot etalon
Inventor: DUBBELDAM GERRIT CORNELIS
IPC: G11B7/246
Filed: 1996-11-28
Abstract: The present invention is in the field of optical recording media, and is directed to an optical recording medium which comprises the following layers; a) a grooved transparent substrate (1), superposed by b) a recording layer comprising a partial mirror (2) of a material having a high complex index of refraction which is not within the pentagon defined by the vertices 7.15 - i3.93, 7.15 - i5.85, 8.96 - 6.28, 9.56 - i5.90, and 8.14 - i3.77 in the n,k plane, superposed by a buffer layer (3) comprising a nonliquid-crystalline high-molecular weight material and optionally a dye, superposed by a thick reflective layer (4), together forming a Fabry-Perot wherein the thickness (d) of the buffer layer within the grooves is set so that the reflection of the medium is in the high reflective state, optionally superposed by c) a protective coating (5). By virtue of the partial mirror, the buffer layer, and the thick reflective layer a Fabry-Perot etalon is created. Information can be written by deformation of one or more of the partial mirror, the buffer layer, the thick reflective layer, or the substrate. The deformation effects change or destroy the Fabry-Perot, and a decrease in reflection is created. As deformation effects are used for writing, a non-liquid crystalline high-molecular weight material can be used in the buffer layer. The tracking (keeping the writing laser within the grooves) can take place by employing the difference in reflected amplitude or phase of the partial mirror/substrate interface within and outside the groove.
Patent NZ-332704-A (NZ)
Title: 8-(substituted phenyl)-tetrahydropteridines and pyridylpiperazines useful in the treatment of neurological disorders
Inventor: WILDE RICHARD GERALD
IPC: C07D471/04
Filed: 1997-05-19
Abstract: A compound of formula I or a pharmaceutically acceptable salt or prodrug thereof is claimed wherein: A is N or C-R11; X is H, OR1, S(O)nR1, NR1R2, CR1R2R3, optionally substituted phenyl or heteroaryl; n is 0 to 2; R1 is alkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, arylalkyl, dialkylaminoalkyl, cyanoalkyl, carboalkoxyalkyl, optionally substituted phenyl or heteroaryl; R2 and R3 are independently H, alkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, arylalkyl, dialkylaminoalkyl, cyanoalkyl, carboalkoxyalkyl, C(=O)CH3, optionally substituted phenyl or heteroaryl; R4 is H, alkyl, allyl, propargyl or optionally substituted benzyl or R1 and R4 together may optionally form with the atoms to which they are attached a 5-9 membered ring with the structural sequence between X and the ring nitrogen being -(CH2)p-W-(CH2)q-; p and q are independently 0 to 2; W is -CH2, C(CH3)2, C(=O), O, S or NCH3; R5 to R8 are independently H, alkyl, allyl, propargyl or optionally substituted phenyl or R4, R5 and R6 may optionally form with the atoms to which they are attached an optionally substituted  tetrazole or imidazole ring or R5 and R6 may also be taken together to be O, S or NR12; R9 is optionally substituted phenyl, pyridyl or pyrimidinyl; R10 is H, alkyl or cyano; R11 is H, alkyl or halogen; R12 is H, alkyl or phenyl. A pharmaceutical composition containing the above defined compound useful for treating an affective disorder, anxiety, depression, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, gastrointestinal disease, anorexia nervosa or other feeding disorder, drug or alcohol withdrawal symptoms, drug additions or inflammatory disorders is claimed.
Patent NZ-333251-A (NZ)
Title: Medical tube and associated magnet for insertion and detection within the body of a patient
Inventor: SOMOGYI CHRISTOPHER P
IPC: A61M5/14
Filed: 1997-06-13
Abstract: There is disclosed a medical tube for insertion into the body of a patient. The medical tube includes a tube or device suitable for insertion into the patient's body, and a permanent magnet associated therewith. The magnet may be solid or non-solid, and may be rigid or non-rigid.
Patent NZ-500959-A (NZ)
Title: Fin sealing of the pane for sashless windows
Inventor: LANGNER ROBERT CHARLES
IPC: E06B3/54
Filed: 1999-11-01
Abstract: A sashless window comprises a window frame and at least one pane of the window mounted in the frame for sliding movement. Vertical sliding pane sealing is achieved through the juxtaposition of fin type seals (67,68) held the vertical pane holding members (60) and the stile members (21,22). Horizontal sliding pane sealing is achieved through the juxtaposition of fin type seals (72,75) held in the horizontal pane holding members (70) and sill adaptor (44).
Patent NZ-501744-A (NZ)
Title: Upstream regulatory element of a synthetic plant core promoter
Inventor: BRUCE WESLEY B
IPC: C12N15/82
Filed: 1997-06-10
Abstract: Disclosed is a nucleic acid molecule that when in combination with a promoter sequence, enables enhanced expression of desired structural genes in both monocotyledonous and dicotyledonous plants.  The nucleic acid molecule is a synthetic upstream element with the following sequence: GGATCCTATG CGTATGGTAT GACGTGTGTT CAAGATGATG ACTTCAAACC TACCTATGAC GTATGGTATG ACGTGTGTCG ACTGATGACT TAGATC
Patent NZ-512256-A (NZ)
Title: Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus
Inventor: ZYBIN DMITRY VLADIMIROVICH
IPC: A61K9/50
Filed: 2001-06-08
Abstract: A polyacrylamide gel is useful in the preparation of a medicament for introducing into the tissue of a mammal to form a connective tissue capsule. Transplanted heterologous cells are then inserted into the capsule formed in the mammal and the cells are cultivated. The transplanted cells produce biologically active components, induce immunity or supplement levels of a substance that is either deficient or absent in the mammal. It is useful for the treatment of diabetes mellitus whereby the cells may be pancreatic b-cells and in treatment of cancer Also described is a method of cultivating heterologous cells within a non-human mammal, which comprises introducing into the tissue a polyacrylamide gel that forms a connective tissue capsule and subsequently introducing the heterologous cells into the capsule.
Patent NZ-518059-A (NZ)
Title: Topical treatment of streptococcal infections using a lysin enzyme coded for by a C1 bacteriophage
Inventor: LOOMIS LAWRENCE
IPC: A61P31/04
Filed: 2000-01-20
Abstract: A composition for treating dermatological streptococcal infections  comprises an effective amount of  a  therapeutic agent.  The  therapeutic agent is produced  by  obtaining  a lysin  enzyme  genetically coded fro by a  C1  bacteriophage and   mixing   the  lysin  enzyme  with  a  pharmaceutically acceptable  carrier  for topical application  of  the  lysin enzyme.  Also  described  are a  time-release  patch  and  a liquid absorbed wipe comprising the therapeutic agent.
Patent NZ-522133-A (NZ)
Title: New thiochromane derivatives and their use as thrombin inhibitors
Inventor: ANDERSSON KJELL
IPC: A61P7/00
Filed: 2001-05-14
Abstract: Formula I (see below) is disclosed wherein Y represents S(O) or S(O)2, R1 represents halo and R2 represents H, halo or C1-4 alkoxy. The disclosed formula is useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular is useful in the treatment of conditions where inhibitors of thrombin is required (e.g. thrombosis) or as anticoagulants.
Patent NZ-527808-A (NZ)
Title: Optical fibre organiser
Inventor: VASTMANS KRISTOF
IPC: G02B6/44
Filed: 2002-03-21
Abstract: An organiser (1) for optical fibers comprises a base tray (2) and a main tray (3), the trays is hingedly connected so as to provide an opened position in which access to the trays is facilitated and a closed position in which the base tray (2) is at least partially covered by the main tray. The base tray (2) comprises at least one port (5) for passing optical fibers into and out of the organiser (1) and guide means (6) for guiding optical fibers within the tray. The main tray (3) has a first side facing away from the base tray (2) and a second side facing towards the base tray (2), both the first side and the second side having guide means (6) for guiding optical fibers.
Patent NZ-528050-A (NZ)
Title: System and method for pushing information from a host system to a mobile data communication device
Inventor: MOUSSEAU GARY P
IPC: G06F17/30
Filed: 1999-05-28
Abstract: A method of redirecting data items from a server system to a plurality of mobile data communication devices, comprises the steps of: - (a) Providing a redirection program (12) at the server system (11); (b) Providing a plurality of desktop systems (26, 28) in communication with the server system via a network (14); (c) Providing a user profile for each of the plurality of desktop systems at the server system, wherein the user profiles each associate a particular desktop system with a particular mobile data communication device (24); (d) Configuring the desktop systems to detect redirection events; (e) Detecting the redirection events at the desktop systems; (f) Transmitting redirection messages from the desktop system to the server system; and (g) In response to the redirection messages, continuously redirecting the data items from the server system to the mobile data communication devices based on the user profiles. (62) Divided out of 508305
Patent NZ-530556-A (NZ)
Title: Variolin derivatives and their use as antitumor agents
Inventor: REMUINAN MODESTO
IPC: C07D401/06
Filed: 2002-07-11
Abstract: Variolin derivatives of the general formula (5) are described. The substituent groups defined by X2, R2, R3, R6, R7 and R12 are each independently selected from the group consisting of H, OH, OR', SH, SR', SOR', S02R', N02, NH2, NHR', N(R')2, NHCOR', NHS02R', CN, halogen, =O, C(=O)H, C(=O)R', C02H, C02R', carboxyalkyl, C1-C12 alkyl, C2- C12 alkenyl, C2-C12 alkynyl, aryl, aralkyl and heteroaromatic. Each of the R1 groups is independently selected from the group consisting of OH, OR', SH, SR', SOR', SO2R', NO2, NH2, NHR', N(R')2, NHCOR', NHSO2R', CN, halogen, =O, C(=O)H, C(=O)R', C02H, C02R', carboxyalkyl, Cl-Cl2 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, aryl, aralkyl and heteroaromatic. The pairs of groups R1 and R2, R2 and R3, R3 and R12, R12 and R6, or R6 and R7 may be joined into a carbocyclic or heterocyclic ring system. Use of the compound is described to be for the preparation of a medicament for cancer treatment.
Patent NZ-541422-A (NZ)
Title: Novel method for synthesising (2S, 3AS, 7AS)-perhydroindole-2-carboxylic acid and the esters thereof and the use thereof for perindopril synthesis
Inventor: DUBUFFET THIERRY
IPC: C07D209/42
Filed: 2004-02-27
Abstract: Disclosed is the production of (2S, 3aS, 7aS)-perhydroindole-2-carboxylic acid derivatives of formula (I) which comprises reacting 1-(1-cyclohexenyl)pyrrolidine with a N-protected 3-iodoalanine derivative, deprotecting the amino group, cyclizing and dehydrating the product, catalytically hydrogenating the product at 1-30 bar, and optionally deprotecting or reprotecting the acid group.
Patent NZ-542199-A (NZ)
Title: Herbicidal mixtures containing picolinafen and a benzoic acid or a quinolinecarboxylic acid
Inventor: ZAGAR CYRILL
IPC: A01N43/40
Filed: 2004-03-12
Abstract: Disclosed is a herbicidal mixture, comprising picolinafen of formula (I) or an agriculturally useful salt thereof, and at least one further herbicide selected from the group of the benzoic acids and quinolinecarboxylic acids.
Patent NZ-553681-A (NZ)
Title: Soft chewable capsule
Inventor: KOH TAI HENG
IPC: A61K9/48
Filed: 2007-03-07
Abstract: Disclosed is a soft chewable capsule having a shell to encapsulate a fill, said shell comprising one or more of either a matrix-forming macromolecular protein or carbohydrate, gelatin or a plant polysaccharide; water; at least 4-20% w/w of one or more of either cocoa butter, cocoa butter equivalent, theobroma oil, or extract thereof, and wherein said capsule is both chewable and melts in the mouth.
Patent NZ-562317-A (NZ)
Title: Injection device with a safety locking mechanism for an actuator for a syringe
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/32
Filed: 2006-03-21
Abstract: Disclosed is an injection device (110), comprising of a housing (112), an actuator (114), a drive (120), and a locking mechanism. The housing is adapted to receive a syringe having a discharge nozzle. The drive is acted upon by the actuator and in turn acts on the syringe to advance it from a retracted position, in which the discharge nozzle is contained within the housing, to an extended position, in which the discharge nozzle extends form the housing. The locking mechanism is in communication with the actuator and activatable to be moved from a locked position, in which the actuator is prevented from releasing the drive, to an unlocked position, in which the actuator is operable to act upon the drive to advance the syringe. The locking mechanism or the housing includes integrally formed biasing means (201) adapted to return the locking mechanism to a locked position when it is not activated.
Patent NZ-563126-A (NZ)
Title: Beam system membrane suspension for a motor mount to reduce the forces exerted on a fan motor
Inventor: HEINZEN WILLIAM J
IPC: B25C1/08
Filed: 2006-05-03
Abstract: A suspension system (26) for a fan motor in a combustion-powered hand tool is disclosed. The system (26) includes a motor retaining ring (28) defining a space for accepting the motor, an outer ring (30) radially spaced from the retaining ring (28) and configured for attachment to the cylinder head of a combustion chamber. At least one resilient suspension element (32) dampens vibrations between the motor support (42) and the tool frame. The suspension element (32) has a plurality of resilient beams (34) connecting the retaining ring (28) and the outer ring (30). These beams are arranged at acute or obtuse angles relative to the retaining ring (28).
Patent NZ-565166-A (NZ)
Title: Code transformation
Inventor: TONKIN RUTH EMMA
IPC: G06F9/45
Filed: 2006-06-27
Abstract: A computer system for transforming code and a method for transforming code to a different programming language are disclosed. The computer system has input means to receive the code; storage means to store the received code, identification data of a plurality of restructuring processes, transformed code and application software; and processing means configured to perform the method of transforming code to a different programming language. This method comprises receiving the code; creating an abstract syntax tree based on the code; storing on a data store identification data on a plurality of re-structuring processes to be run on the abstract syntax tree to re-structure the tree to aid the transformation of the code to the different language; automatically running the re-structuring processes identified in the data store on the abstract syntax tree; automatically running a deployment process on the restructured tree to transform the code to the different programming language; storing the transformed code in the data store; assessing the transformed code and based on this assessment identifying a further re-structuring processes to be run on the abstract syntax tree to aid the transformation of the code to the different language; storing on the data store identification data of the further re-structuring process; and repeating the running steps and storing transformed code.
Patent NZ-567077-A (NZ)
Title: An online rental property financial reporting application and method
Inventor: WELLS GREGORY REXFORD
IPC: G06Q40/00
Filed: 2008-03-31
Abstract: An online rental property financial reporting application is disclosed. The application is arranged to provide a member access to the application, receive financial data from the member, and allocate the financial data to multiple rental properties associated with the member and to multiple tax entities associated with the member. The member includes a plurality of different tax entities that are the legal owners of one or more of the rental properties.
Patent NZ-567312-A (NZ)
Title: Botulinum neurotoxin a protein receptor and uses thereof
Inventor: RUMMEL ANDREAS
IPC: C07K14/33
Filed: 2006-10-30
Abstract: Disclosed is an isolated polypeptide of the luminal domain (amino acids 454-579) of the synaptic vesicle glycoprotein 2C of Homo sapiens, the isolated polypeptide binding the Hc fragment of botulinum neurotoxin A. Also disclosed are antibodies that reduce the binding of botulinum neurotoxin A to the disclosed luminal domain and the use of said antibodies for the reduction of neurotoxicity of botulinum neurotoxin A in mammals.